Mumbai (Maharashtra) [India], June 1: Unihealth Hospitals Limited (NSE: UNIHEALTH | INE0PRF01011), a rapidly expanding healthcare platform with operations across India and East Africa, today announced its audited financial results for H2 FY26 and FY26. The Company delivered another year of strong growth, marked by robust revenue expansion, improving profitability, strategic capacity additions, and significant progress on its long-term vision of building an integrated healthcare ecosystem across underserved and high-growth markets.

Driven by rising patient volumes, increasing demand for specialized healthcare services, operational efficiencies, and successful expansion initiatives, Unihealth continues to strengthen its position as a differentiated healthcare provider focused on delivering quality, affordable, and accessible healthcare.

H2 FY26 Consolidated Key Financial Highlights

  • Total Income of ₹67.45 Cr, YoY growth of 18.44%
  • EBITDA of ₹24.20 Cr, YoY growth of 7.26%
  • EBITDA Margin of 35.88%, YoY decline of 374 Bps
  • *Net Profit of ₹10.72 Cr, YoY growth of 19.04%
  • Net Profit Margin of 15.90%, YoY growth of 8 Bps
  • Diluted EPS of ₹6.86, YoY growth of 17.26%

FY26 Consolidated Key Financial Highlights

  • Total Income of ₹137.01 Cr, YoY growth of 34.61%
  • EBITDA of ₹58.82 Cr, YoY growth of 48.91%
  • EBITDA Margin of 42.93%, YoY growth of 412 Bps
  • *Net Profit of ₹25.83 Cr, YoY growth of 82.87%
  • Net Profit Margin of 18.85%, YoY growth of 498 Bps
  • Diluted EPS of ₹16.52, YoY growth of 80.15%
     
     *Net Profit for the period reflects only the portion attributable to the owners of the Company.

H2 FY26 Standalone Key Financial Highlights

  • Total Income of ₹7.70 Cr, YoY growth of 102.29%
  • EBITDA of ₹5.32 Cr, YoY growth of 186.41%
  • EBITDA Margin of 69.05%, YoY growth of 2,028 Bps
  • Net Profit of ₹3.77 Cr, YoY growth of 214.62%
  • Net Profit Margin of 48.92%, YoY growth of 1,747 Bps
  • Diluted EPS of ₹2.46, YoY growth of 211.39%

FY26 Standalone Key Financial Highlights

  • Total Income of ₹13.23 Cr, YoY growth of 92.54%
  • EBITDA of ₹9.17 Cr, YoY growth of 158.16%
  • EBITDA Margin of 69.34%, YoY growth of 1,763 Bps
  • Net Profit of ₹6.49 Cr, YoY growth of 176.32%
  • Net Profit Margin of 49.07%, YoY growth of 1,488 Bps
  • Diluted EPS of ₹4.15, YoY growth of 171.24%

The strong performance underscores the scalability of Unihealth’s business model, which combines hospital operations with healthcare consultancy, medical value travel, pharmaceutical exports, and healthcare infrastructure development. This diversified approach enables the Company to capture multiple opportunities across the healthcare value chain while creating sustainable long-term growth.

Building a Cross-Border Healthcare Platform

Over the past decade, Unihealth has evolved from a healthcare services company into a multi-dimensional healthcare enterprise with a growing presence across emerging markets. Today, the Company operates an integrated healthcare network that serves patients across India and East Africa, regions characterized by growing populations, increasing healthcare awareness, rising disposable incomes, and significant demand-supply gaps in quality healthcare infrastructure.

The Company’s strategy focuses on establishing high-quality tertiary and specialty healthcare facilities in underserved markets while leveraging Indian medical expertise, global clinical standards, and localized partnerships. This model enables Unihealth to deliver world-class healthcare outcomes while maintaining affordability and accessibility for patients.

With more than 600 employees and an expanding network of healthcare professionals, Unihealth continues to build a healthcare platform designed to address both current healthcare needs and future demand across its operating geographies.

Transformational Year of Expansion

Major milestones during FY26 were the successful commissioning of UMC Hospitals, Navi Mumbai (India), finalizing the lease for the 200-bedded UMC Hospital in Nashik (India) and the acquisition and commissioning of UMC Hospital, Entebbe, Uganda. These strategic additions significantly strengthen Unihealth’s footprint and reflect the Company’s commitment to building a leading healthcare network in high-growth markets across India and Africa.

These transactions increased Unihealth’s overall bed capacity from 200 beds at the start of FY26 to 400 beds, substantially enhancing its ability to serve growing patient demand. 

Beyond financial performance and expansion, Unihealth remains focused on advancing clinical outcomes and improving patient experiences. During FY26, the Company achieved a significant milestone with the first successful IVF twin birth at UMC Victoria Hospital in Uganda, marking an important achievement for its IVF and Fertility Department and demonstrating the growing capabilities of its specialty healthcare services.

The Company continues to invest in advanced medical technologies, specialized clinical programs, and high-quality healthcare professionals to enhance patient outcomes and strengthen its reputation for clinical excellence.

The Navi Mumbai and Nashik projects reflect Unihealth’s confidence in the long-term opportunities within India’s healthcare sector, which continues to benefit from increasing healthcare expenditure, expanding insurance coverage, demographic shifts, and growing demand for quality medical infrastructure.

Commenting on the Company’s performance, Dr. Akshay Parmar, Founder & Managing Director, Unihealth Hospitals Limited, said: “FY26 marks a defining year in Unihealth’s growth journey. We delivered strong financial performance while simultaneously executing key strategic initiatives that significantly expanded our healthcare platform. Our ability to achieve robust revenue growth, improve profitability, and nearly double our bed capacity reflects the strength of our operating model, disciplined execution, and the trust patients place in our healthcare services.

Our vision extends beyond operating hospitals. We are building a healthcare platform that combines clinical excellence, accessibility, innovation, and affordability. By leveraging our expertise across healthcare delivery, consultancy, pharmaceuticals, and medical value travel, we aim to create a sustainable ecosystem that improves healthcare outcomes while generating long-term value for all stakeholders.

As we look ahead, our priorities remain centred on integrating and scaling our expanded network, progressing the Navi Mumbai and Nashik hospital projects, strengthening our healthcare offerings, and driving sustainable growth across all our operations. With a significantly larger capacity base, a strong presence across multiple geographies, and a clear expansion roadmap, we believe Unihealth is well-positioned to capitalize on the opportunities ahead and create long-term value for patients, communities, and shareholders.”

Commenting on the outlook, Dr. Anurag Shah, Founder & Director, Unihealth Hospitals Limited, added:

“Our FY26 performance demonstrates the resilience and scalability of the foundation we have built over the years. Alongside expansion, we have remained focused on operational excellence, resulting in meaningful improvements in profitability and efficiency. Rising patient volumes, a richer service mix, and disciplined cost management have all contributed to our strong performance.

The successful acquisition of UMC Hospital, Entebbe, represents a transformational step in our evolution as a regional healthcare provider in Africa. Across East Africa, we continue to see significant unmet demand for quality healthcare infrastructure, specialized treatments, and advanced medical services. We believe these markets offer substantial long-term opportunities, and Unihealth is uniquely positioned to address them through its integrated healthcare ecosystem.

Looking ahead, our focus will remain on maximizing utilization across our expanded network, integrating recent acquisitions, strengthening specialty healthcare services and expanding referral partnerships. With a larger operational footprint, enhanced capabilities, and a clear strategic roadmap, we are confident in our ability to sustain growth momentum and continue delivering high-quality healthcare to the communities we serve.”

Growth Outlook

Unihealth enters FY27 with strong momentum supported by:

  • Expanded healthcare infrastructure and increased capacity
  • Growing demand for quality healthcare services across India and East Africa
  • Strengthening specialty and tertiary care capabilities
  • Continued development of the Navi Mumbai and Nashik hospital projects
  • Increasing healthcare awareness and affordability in emerging markets
  • Opportunities to enhance operational efficiencies across the expanded network
  • A strong balance sheet and disciplined capital allocation strategy

The Company remains committed to its mission of “Healthcare for All” and continues to pursue sustainable growth through strategic expansion, clinical excellence, innovation, and patient-centric care.

About Unihealth Hospitals Limited

Founded in Mumbai in 2010, Unihealth Hospitals Limited is an integrated healthcare platform focused on delivering affordable, accessible, and high-quality healthcare services across India and East Africa. The Company operates across multiple healthcare verticals, including hospital operations, healthcare consultancy, pharmaceutical and consumables exports, and medical value travel.

Through the Unihealth–UMC Hospitals network, the Company combines Indian clinical expertise, global healthcare standards, and localized partnerships to create a scalable healthcare ecosystem serving diverse patient populations across emerging markets.

Driven by its mission of “Healthcare for All,” Unihealth continues to expand its healthcare footprint while creating long-term value for patients, communities, healthcare professionals, and shareholders.

The Company was listed on NSE Emerge in September 2023.

For FY26, the Company reported consolidated Total Income of ₹137.01 Cr, EBITDA of ₹25.83 Cr, and Net Profit attributable to the equity shareholders of the Company of ₹25.83 Cr.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.